Oral anticoagulation therapy : cases and clinical correlation /: cases and clinical correlation. ([2017])
- Record Type:
- Book
- Title:
- Oral anticoagulation therapy : cases and clinical correlation /: cases and clinical correlation. ([2017])
- Main Title:
- Oral anticoagulation therapy : cases and clinical correlation
- Further Information:
- Note: Kathryn Kiser, editor.
- Editors:
- Kiser, Kathryn
- Contents:
- Part I: Introduction; Chapter 1: Introduction; Part II: Atrial Fibrillation; Chapter 2: CHA2DS2-VASc and HAS-BLED Risk Stratification Tools; Case Introduction; Case Discussion; Risk of Stroke; Risk of Bleeding; How Does a Clinician Choose Among the Various Agents for Stroke Prevention?; Key Points; Self-Assessment Questions; References; Chapter 3: Male with Priority of Ischemic Stroke Reduction; Discussion; Key Points; Self-Assessment Questions; References; Chapter 4: Choosing an Anticoagulant in an Elderly Patient; Case Introduction; Case Discussion; Key Points. Self-Assessment QuestionsReferences; Chapter 5: Patient with Prior History of GI Hemorrhage; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 6: Patients with a History of Intracranial Hemorrhage; Case Introduction; Key Points; Self-Assessment Questions; References; Chapter 7: Concerns with Anticoagulant Adherence; Key Points; Self-Assessment Questions; References; Chapter 8: Oral Anticoagulants in Stable Moderate Chronic Kidney Disease; Case Introduction; Case Discussion; Background. What Factors Should be Considered When Selecting an Oral Anticoagulant for Patients with Stable Moderate Renal Function? The Outcome; Key Points; Self-Assessment Questions; References; Chapter 9: Oral Anticoagulants in Severe Renal Dysfunction; Case Discussion; What Is this Patient's Risk of Stroke and Bleeding?; What Is the Evidence for Use of Direct Oral Anticoagulants (DOACs) in SeverePart I: Introduction; Chapter 1: Introduction; Part II: Atrial Fibrillation; Chapter 2: CHA2DS2-VASc and HAS-BLED Risk Stratification Tools; Case Introduction; Case Discussion; Risk of Stroke; Risk of Bleeding; How Does a Clinician Choose Among the Various Agents for Stroke Prevention?; Key Points; Self-Assessment Questions; References; Chapter 3: Male with Priority of Ischemic Stroke Reduction; Discussion; Key Points; Self-Assessment Questions; References; Chapter 4: Choosing an Anticoagulant in an Elderly Patient; Case Introduction; Case Discussion; Key Points. Self-Assessment QuestionsReferences; Chapter 5: Patient with Prior History of GI Hemorrhage; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 6: Patients with a History of Intracranial Hemorrhage; Case Introduction; Key Points; Self-Assessment Questions; References; Chapter 7: Concerns with Anticoagulant Adherence; Key Points; Self-Assessment Questions; References; Chapter 8: Oral Anticoagulants in Stable Moderate Chronic Kidney Disease; Case Introduction; Case Discussion; Background. What Factors Should be Considered When Selecting an Oral Anticoagulant for Patients with Stable Moderate Renal Function? The Outcome; Key Points; Self-Assessment Questions; References; Chapter 9: Oral Anticoagulants in Severe Renal Dysfunction; Case Discussion; What Is this Patient's Risk of Stroke and Bleeding?; What Is the Evidence for Use of Direct Oral Anticoagulants (DOACs) in Severe CKD?; What Are Considerations When Using Warfarin in CKD?; What Is the Best Anticoagulation Plan for this Patient?; Key Points; Self-Assessment Questions; References. Chapter 10: Oral Anticoagulants in Patients with Variable Renal Function Case Introduction; Case Discussion; Background; Considerations for DOAC Management in Variable Renal Function; Upon Admission; Case Continuation; Prior to Discharge; Case Continuation; During Hospitalization Follow-up; The Outcome; Key Points; Self-Assessment Questions; References; Chapter 11: Patient with Concomitant Stable Coronary Artery Disease; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 12: Patient with Concomitant Acute Venous Thromboembolism; Case Introduction. Case Discussion Key Points; Self-Assessment Questions; References; Chapter 13: Patient with Concomitant Mitral Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self-Assessment Questions; References; Chapter 14: Patient with Concomitant Aortic Valve Stenosis; Case Introduction; Case Discussion; Key Points; Self Assessment Questions; References; Part III: Warfarin Management; Chapter 15: Best Practice for Switching Stable Warfarin Patients; Case Introduction; Case Discussion; FDA-Approved Indications for Use; Comparison of DOACs with Warfarin. … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2017
- Copyright Date:
- 2017
- Extent:
- 1 online resource
- Subjects:
- 615.7/18
Anticoagulants (Medicine) -- Case studies
Oral medication -- Case studies
MEDICAL -- Pharmacology
Anticoagulants (Medicine)
Oral medication
Medicine & Public Health
Cardiology
Electronic books
Case studies
Electronic book - Languages:
- English
- ISBNs:
- 9783319546438
3319546430
3319546414
9783319546414 - Related ISBNs:
- 9783319546414
- Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from PDF title page (EBSCO, viewed June 8, 2017). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.398702
- Ingest File:
- 02_427.xml